Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FY.5.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.53EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19092.4South Korea
P.2 (Zeta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.499EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.212EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.58.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCMEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.42.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used